Bottom line
BOUT vs FFTY: the short answer
BOUT (CapForce IBD Breakout Opportunities ETF) and FFTY (Innovator IBD(R) 50 ETF) are both etfs.
Updated Nov 19, 2026
BOUT vs FFTY side by side
| BOUT | FFTY | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Capforce Ibd Breakout Opportunities | Innovator |
| Category | Other | Other |
| Expense ratio | — | 0.8% |
| Annual cost per $10k | — | $80 |
| 10-yr cost on $10k (prospectus) | — | $1,239 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | — | +23.5% |
| 5-yr return (annualized) | — | −2.1% |
| 10-yr return (annualized) | — | +5.3% |
| Best quarter | — | +23.2% |
| Worst quarter | — | −31.2% |
| Net assets (fund) | — | — |
| Number of holdings | — | — |
| Portfolio turnover | — | 1,209% |
| Returns as of | — | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
FAQ
What is the difference between BOUT and FFTY?
BOUT (CapForce IBD Breakout Opportunities ETF) and FFTY (Innovator IBD(R) 50 ETF) are both etfs.
Should I own both BOUT and FFTY?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.